71 results

• Motion to Dismiss Valsartan Contamination Claims Will Not Be Addressed by MDL Court

  August 21, 2019

  Irvin Jackson

  A federal judge is refusing to consider a motion to dismiss valsartan recall class action lawsuits, saying defendants should focus more on how their pills got contaminated with cancer-causing impurities.

• Valsartan Recalls May Have Been Caused By Indian Solvent Recovery Firm, At Least In Part: FDA

  August 16, 2019

  Irvin Jackson

  A solvent company in India received a warning letter from the FDA, indicating it may have played a role in massive generic valsartan recalls issued over cancer-causing impurities.

• Valsartan Impurities Caused Stomach Cancer, Wrongful Death Lawsuit Claims

  August 12, 2019

  Irvin Jackson

  A wrongful death lawsuit blames recalled generic valsartan for a man's fatal case of stomach cancer.

• Valsartan Pancreatic Cancer Diagnosis Resulted in Wrongful Death, Lawsuit Alleges

  August 7, 2019

  Irvin Jackson

  A wrongful death lawsuit claims recalled generic valsartan tablets containing manufacturing impurities caused a man's lethal case of pancreatic cancer.

• Valsartan Prostate Cancer Lawsuit Filed Over Recalled Blood Pressure Drug

  July 29, 2019

  Irvin Jackson

  A prostate cancer lawsuit filed against the makers of generic valsartan say tainted pills caused a man's cancer to return and spread to his bones.

• Valsartan Renal Cancer Lawsuit Alleges Recalled Drug Resulted in Diagnosis, Need For Kidney Removal

  July 22, 2019

  Irvin Jackson

  A valsartan lawsuit claims cancer-causing impurities in recalled generic tablets resulted in kidney cancer and the need for kidney removal.

• Side Effects of Recalled Valsartan and Losartan Caused Kidney Cancer, Lawsuit Alleges

  July 18, 2019

  Irvin Jackson

  A valsartan and losartan recall lawsuit claims tainted hypertension drugs led to a kidney cancer diagnosis.

• Valsartan Recalls Resulted in Increase In Reports of Cancer Among Former Users: Report

  July 15, 2019

  Irvin Jackson

  A new study questions the increase in cancer-related reports linked to valsartan following a series of recalls that began last summer, saying they may have been the result of alarm among consumers and healthcare professionals.

• Procedure For Filing New Valsartan Recall Claims Through Short-Form Complaint To Be Discussed During Status Conference

  July 9, 2019

  Irvin Jackson

  Parties involved in valsartan recall lawsuits will discuss putting in place short form filing procedures at a status conference tomorrow.

• Valsartan Problems Lead To Warning Letter For Aurobindo

  July 3, 2019

  Irvin Jackson

  An FDA warning letter to generic valsartan drug manufacturer Aurobindo accuses the company of failures in oversight and quality assurance of its generic drug products.